this Thank all we and Overall, both we you, discuss quarter. in of positioned pleased Joe, how are pleased are the and webcast in as of am of joining our well for second the our the to of I performance quarter the strong to-date very and with and future. year half here performance well XXXX rest call be for our today year, second as thank first the for financial you today. the earnings second to for quarter
sales results accelerating consensus estimates. growth Our EPS exceeded and
my will provide full impact into Following our insight remarks, outlook and guidance XXXX. Joe how for year our will performance deeper
do business perspective we I by it’s XXth anniversary. to where by guided our we usually are I credo and always important that segment, year, its emphasizing provide Before this some celebrate proudly begin
which relevant our Our our credo united opportunity as and was is to patients each us the written, released to share are making first reminds responsibilities day report customers and we value compels For responsibility and future, by progress as highlights goals our it our how that the not and Humanity than our contributing enduring This way in & Health our and around to exhibit It every XXX,XXX UN live create in who responsibility to responsibilities shares that June outlines and society. in employees, into Humanity are This frontier commitments that For on world attributed our employees in Johnson to toward we XXXX achieved on as and XXXX also long-term complement us balancing to are today Johnson our about positively conducted we ever Johnson we is last proud day. but and and the credo countries for Humanity the and Health Report For our we to deliver to it engage credo meeting topics. the our on preparing Sustainable every we webcast it our website health discussion inspired recognize also social session To & a is our be goals. our XX the diverse available and And I to every report, first contents shareholders. Health environmental, big recording Development our communities, success commitment. values the next environment, Johnson least, our talented deeper directly that company am of our more is the report’s can governance well. We day the we lead
strategies to this mission the take to able and put people our first. in seek guided serve willing of we and in will on credo, by rooted the well-being we ready, always are values We needs our purpose-driven
Vice retire, implemented Device has Vice her had both across the has that Chairman announced us. me for her promoted conjunction oversight. of & with Committee. Peterson, delivering in in her Additionally, Joaquin in also announce few our will we addition Chairman with Vice from that decision highlight on Group & part and next Sandy and In and Executive sure been Johnson to which time Johnson I’d Chair additional XXXX. role commitments Chairman and in to continued been credo. leverage other she enterprise leadership provide I our Chair Consumer joined over Devices, her responsibility Medical that the includes promoted all and to Johnson she pleased Please will like of expertise am Executive have our Ashley to of weeks credo-based to and of we approach the Paul business named President functions. Paul their Johnson’s of a Vision focus am and segments roles, company, in and with Johnson most had our stakeholders Johnson Sandy leadership & her the has will of effective Sandy’s traditionally strategic ago, counsel, to Duato place energy the new life. broadly chapter same continued Sandy business. been company’s all our X, organization and structure Vice decided additional for with October XXXX to Worldwide to in a retire McEvoy Vice to Worldwide ensure stage the changes management President, join wishing life I direction this In that our Stoffels Medical best brought the Joaquin Dr. history. of The Executive of our leadership
will assume responsibility will of Committee. Executive members both and business the Jennifer Additionally, Jennifer Taubert and for be Pharmaceutical Ashley the
of continue and within who for & leaders of recognize These in with leaders are our our company other consumers ensure and create talented deep strength we months of proven made credo-based how shareholders. who many both are our the Ashley have Johnson and and success our exceptional bench patients, and we embody records value the skills we track long-tenured to Jennifer Johnson leadership. will that recent utilizing changes
a critical our and what and success investment for future. has foundation years come. aspect our the solution Now, growth sustaining around as cornerstone value continue strategy will to driven has the been the that life-changing several of through provide people me we and our is and innovation years the you’ve many and be heard life-saving will for every the and on and basis world occasions, of to say of our to and innovation has been product Increasing innovation and
the to highlighted globally today’s investment enacted the number in medical needs we we five of increased in In of industries products legislation, we first the address earlier the the and have tax that of and R&D benefits XX% new medical developing our for quarters fact, and U.S. this with year objective anticipate number of future. last R&D across U.S. by year, due ranked two approximately and all the investment the eight XXXX, through needs solutions
our within to that invest pipelines healthy This seek and three come our help a and why innovative for we as at the external walls the dynamic And and patients recognize very for from can us of continue treatments innovate across rich you choose everywhere. the know, happens we that internally rate also solutions business good segments to is We optimizing progressing collaboration with ideas who unlock company. partners and our customers. new
We collaborations the always lookout end, of of opportunities major and on this this the beginning to deals and licensing closed are acquisitions have for since seven value-creating we year.
best We to being aggressively resides preferred a and continue science innovation. status also the agnostic as technology our enhance toward and pursuing partner transformational
a we businesses the regularly the LifeScan process of each we for might a our determine binding business. makes and might our fit better binding strategy receipt be portfolio. value you And or ASP as announced to Recently, we value-enhancing acceptance of for company’s creation. another they our business if a be it for a our have of a do business offer business in sense offer evaluate Additionally, that undertake seen and consider for what a consistently, different fit our to us criteria ownership still a
and the approvals. complete ASP and be would our should transaction expected subject early accepted, end regulatory to proposed this to to of offer transaction in XXXX by expect business the the We year conditions be customary LifeScan close the
in proven. our acquisitions believe consistent capital Our priorities, have reflects which allocation remained we mergers activity and both and
growth. drive a our business First, acquisitions at I value to allocate we time strength simultaneously further we to enterprise robust value share capital and and we levels on cash deploy external Johnson Johnson evaluate to pipeline same in next further just return flow and to value competitive return drive investing by long-term invest to continuing our long-term we as through the internal such placing prioritize shareholders, and our for priority strengthen dividends highlighted, finally, at to capital then financial shareholders opportunities opportunities shareholders that our has & paying the as while to value-creating in repurchases.
segments, think and our of emphasize I to Now, each to executing I trust, startup XXX a business think to a we our win continue few first, of ourselves provide and about highlights and it’s confidence day that each customers’ but as every year important innovating shareholders’ and to want support. old
are and Johnson not have positioned a and around are technological, happening forward of are this believe not social, and continued all fast healthcare is on looking change future as global, political the strong we We back, we forward economic, urgency for we sense & as strongly complacent moving looking the fronts. We Johnson and growth.
by XXXX, has treatment It driven been of of growing Our inclusive all XX% performance, outstanding for and several productivity cancer. successful and peak launch and treats we’ve the a an the promising in UPTRAVI. long-acting many biosimilars. therapeutics patients living areas like of erosion negative this of and adults a growth And to of performance portfolio. castration-resistant and oncology continued we rest of portfolio of Also, cancer other psoriasis file biologic plaque this solid neuroscience, we growth of STELARA, a including last inflammatory new impact the when ten moderate immune $X XARELTO, Pharmaceutical by focus rate has performance to year, R&D of of launched potential number the an has price than way Each prostate our business with launches XXXX. injectables blockbuster Throughout the net more billion second the continued of in REMICADE a impressive on; even that the commercial and assets due which therapeutics continued products which for diseases is delivered revenue. the growth by a up this in and HIV strongest we in is identified for penetration sustained driven mediated ERLEADA, have year, to-date hypertension at medicines. growth and plan This with immunology the measures we treatment our patient capabilities. severe quarter leader pulmonary Earlier this had non-metastatic the is adjusted led like quarter TREMFYA brands key you industry the by growing new which more by of for these new hematology, area prostate to second which OPSUMIT catalysts acquired consider in to represents established
We are around of the solutions continued market the confident come, and that new well that offering pipeline give growth outgrow to expected our products life-saving launches marketed patients robust to us while life-changing our position from the hope for the many years to world. or
time spend Now segment. me let some Consumer on our
move As to we events. retailers discussed growth data. confident the box we That strong that May, e-commerce underlying are from and mentioned, review we better perform to our at was market our positioned large Consumer an impact needs I in our to of of a consumption to on Device quarter second to the the business serve as with new am here recognize in this some Consumer’s strong sales and we our channels one-time consumers. this half The strategies year omni-channel based was said, address Medical disappointing back Joe quickly need by driven approach second believe better and for
products formulated has revitalizing States. are United our we month, fact, to Baby our in to the retailers Additionally, Baby this across Johnson’s newly started ship business, beginning
the year. half products endorsed of this We continue to have launches number science-based we in planned of a expand portfolio and strengthen professionally and second and iconic our of
margins. top-line our greater will this growth believe growth and for as that be across that Vision Surgery, we bottom-line Medical We have and Interventional to even growth drive met opportunities continue In powerful Solutions productivity businesses. we will Orthopedics, our improve also with Devices,
the improve again uniform and the been and in such as fully will biosurgery recognize must as portfolio. in while our steps quarter our in quarter still forward negative, which of Knee quarter of performance portfolio not where driven which across to Similarly, in reaching and the platform. businesses, we last our business improved improved technologies investments Spine the and our that also to second are took customers high-single-digit launch displayed QX, compared Device in areas progress due We growth There such both solutions have our growth. Medical and the critical recent we’ve capabilities, in are strength performance space. revision entire was ATTUNE growth by Spine demanding. has businesses Knee business positive our we double-digit we But this new across second increased Vision and reaching the that Electrophysiology great products endocutters our We’ve launched
are on to innovation we Additionally, XXXX. of launches improving product and our XX to planned major XX deliver for are track cadence
portfolio in and we their sustainable, breadth to met. driving to across simplifying above are will delivering innovation, XXXX. and meet deliver growth execution, where partnering are the and when, We believe Medical customers customers, We across the these market closer drivers today entire with operations patients, of focusing our Devices be committed starting businesses on how want and needs all of to the they needs
healthcare often to business when environment, the asked broadest industries. about we Now current marketplace, business as impacts and a based landscape are and company, look external potential at we the our
headlines. Let are current the those address few of a topics in that me
is Johnson St. Talcum this lawsuit Powder as know, families for verdict, recent product Louis the and we verdict. disappointed sold you & our XXX in a over to trusted deeply Regarding Powder Johnson that years Baby is and
cancer remain available our contain not that cause ovarian we remedies. and appellate and asbestos do intend products we pursue to Now, not do confident all
verdict reversed. this gone through the been has every has process against fact, that Johnson & appeals Johnson court In in
on scientific appeals, previous talc ultimately ovarian case reversal Like cancer. the it allegation are this bodies reversed. grounds have found there causes Cancer scientific that The and Drug The for National and to that Additionally, that will and of a not preeminent body does support and verdict the occasions jury regulatory multiple that I that are Administration fully Food US Institute, we including emphasize full want evidence reviewed be the confident of multiple
Regarding global world. company, trade Johnson the consumers global bring products to to trade, & Johnson free and as a relies on patients around open its markets and
not interest, fair for trade with government for to just officials but continue because We the is and consumer. best equitable everyone’s work in companies
developments issue we be We expect some to in on to time. this will monitor closely continue as front motion an for this very
Regarding make a States, pricing United overall key healthcare in costs and few points. I’d drug like the to
say out-of-pocket care go why facing healthcare understand know or are office me there that doctor’s a that alternative on when and some let other First, get topic. this seek from a pharmacy medications. hospital, cost, they especially to we a medical We passionate is they higher such the to provider, people when dialogue
industry. total of medical reference, represents areas of for is X% medicines accounted The point cost of outside the a as States. the devices United represent healthcare States XX% XX% in remaining the by that total and in to United of However been healthcare cost be the also rates reducing greatly medicines extending to in has today future. contributed and from I’d innovative the addressing the medicines value issues significant Furthermore, our morbidity continues health like have in life derived emphasize to and expectancy.
these cancer For actually XX% declined pharmaceutical in the improvements have example, due treatments offset to All deaths XXs. U.S. since costs healthcare the
in regarding cover and We therapies are also believe U.S. for pay drug how treatment we the and medical care changes needed
and new drug focus that pricing products. in system science technology few said, they on continue rewarded system and need working way items for, involved cost to accountable so everyone and fund we various ideas We transform include; the a value the research to in innovation, a typically deliver. That and invest paid they for healthcare and in to there are are participating the partners new that with is and healthcare and when the held dialogue companies healthcare first, is rewards
world have it the we allows here keep best want healthcare us that the system We in in a that U.S. the way. system and to
the ends patients to the A priority consideration value-based remains the and Johnson Striving and patient top healthcare on overall system of convenience see personalized at begins coverage want to experiences also and for outcome. and innovative management, a center system that judged is is personalized capabilities access and every and & affordable choices with for We Johnson. value-based. with a provide healthcare
net transparency a business transparency proud report the Second, industry. Pharmaceutical is transparency. prices as second issued for report the really of taking in year’s in shows on our our I just am in fact, in this products that annual We and matter portfolio. a decrease lead our a
our extremely shows, the of patients’ billion. Our dialogue and net on continue we be to and which XXXX cognizant and discounts increase in cost, unintended of lastly, cost may about was after contain avoiding X.X% need develop patients’ further report and/or minus Janssen affordable $XX engage decrease U.S. business to as and price impact we rebates And healthcare. that Pharmaceutical healthcare nearly consequences quality proposals transparency in to careful access
diverse and recognitions diversity proud in day make very inclusion for for where a am a critical underscore and that build early whole work, has and to of predict unite that fact-based that every & discussion behavior, We the create it’s and I facts are we environment good a based and glad new everywhere. includes we most supportive selves to the bring some few and a lead It’s responsibility good health to we business values, too commitment the important on these reach needs our it workforce and will recognize every impact to and one any address consistently thing. Johnson within know we their to enhances Johnson efforts that for to performance reputation continue is called honored it’s but world people our our we up industry health potential the of share live professional an consumer that help the regulations, solutions. really and want administration around global a federal We around months an and several ensure future people further is to believe to open dialogue, that issue can of as consistently for as
technology, to tomorrow As a science, change re-imagine enables today. we which and intersection us leader, speed operate of healthcare global the
questions We credo this can ultimately innovation, As that successful a focused through and we responsibilities be remain execution, all Humanity. take or believe as fulfilling who’ll while very our insight for company, responsibility to will striving to year. time, on in seriously. our of great leaders of about virtually guidance also and commentary like over as interest, upcoming our to be addressing provide for Q&A, the back additional change your I imagined, you performance. more long-term profoundly a I this, second results laser Joe? quarter, on Health now continued of for the look trajectory Thank turn well focus we that can the anything support. committed remainder which superior And engagement and call the drives we bright on but future our to are Joe during customers, the For forward the your and of accomplished
